Expensya, a specialist in business expense management, announces the successful closing of a $20 million funding round. The round is led by two new funds, French fund MAIF Avenir and international venture capital fund Silicon Badia, which are investing in the development of the fintech company. Previous investors ISAI and Seventure, which were already involved in the last financing round, are also participating again.
Expensya recorded growth of almost 100% in Germany despite the current crisis. This confirmed the dynamic development and attractive corporate strategy of the fintech provider, which offers its customers a 360° solution worldwide. The high market and growth potential also convinced the two new investors: MAIF Avenir and Silicon Badia. The financing round is seen as a promising prospect for the French-Tunisian company, which was only founded in 2014.
Read more about Expensya and find the most important financial news in the world with the Born2Invest mobile app.
Expensya accelerates development in Germany
The two investors MAIF Avenir and Silicon Badia have recognized the great potential and ambitions of the fintech company Expensya: to offer the most comprehensive payment and expense management software solution on the market. It captures all costs such as expense reports, operating costs, online payments, travel expenses, etc.
Thanks to its 360° complete solution and extensive market expertise, Expensya’s users benefit from managing all their expenses Expensya recognized the market’s need for a comprehensive and flexible solution early on and successfully addressed it.
As an end-to-end solution with an intuitive user interface, the solution can adapt to the needs of companies of all sizes – from micro-enterprises to large corporations. 25% of the funding is to be invested by Expensya in research and development of its solution, particularly with regard to the introduction of new payment methods. The remainder is to accelerate international growth.
Team gears up for the future – post planned in Germany
With the funding round, Expensya intends to continue its expansion in Germany, strengthen its presence in all countries in continental Europe and become the market leader for expense management. For this purpose, the current team consisting of 140 people is to be enlarged. With the new capital, Expensya plans to recruit more than 100 new employees over the next three years. Seven new positions are planned in Germany.
Expensya is planning new positions for management, sales, marketing, and partnership management. Just recently, the Paris head office appointed Stéphanie Rogeau-Barré as administrative and financial director and Fabrice Clauzon as director of strategic partnerships. Nicolas Deswarte became part of the team as marketing director and Mario Roche as vice president of sales. The Board has been joined by Anh-Tho Chuong Degroote, Growth Marketing Expert.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in moneycab, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Citi Announced a $6 Million Loan to Sempli for SME financing
The credit granted by Citi was given in partnership with high-impact investors and multilateral development organizations. They all seek to...
How Will the Price of Ripple and Cardano Develop in the Next Few Days
The BOLL indicator shows no specific pattern and denotes the support price of $0.4969 and the resistance price of $0.5059,...
RADEEF: a 182 Million Dirham Plan to Combat Flooding in Morocco
RADEEF is also planning major expansion projects. Firstly, it plans to launch work on extending the wastewater treatment plant. The...
How Institutional Investors Feel About Impact Investing
Investors continue to face greenwashing when implementing impact investing. Among their key concerns are misleading or exaggerated impact claims (60%),...
Biotech1 week ago
AbolerIS Pharma Closes a Round of €27 Million Led by Caixa Capital
Crypto2 weeks ago
BitBoy Crypto Ends Partnership with Youtuber Ben Armstrong
Business3 days ago
Current Woes in Bonds Promise Future Grief for Stocks: Focus on Dow Jones
Business1 week ago
Your Small Business Phone Is Scaring Away 94% of Your Clients. Here’s How to Fix it With Air Landline